Project
Last Updated on June 20, 2022
Substandard & falsified medical products pose a threat to patient & population health and undermines the success of the Sustainable Development Goals. This project examines the public health & socioeconomic impacts of these products and analyzes data from the WHO Global Surveillance & Monitoring System which captures, for the first time, global reporting on substandard and falsified medical products.
Themes | Global Health Foresighting |
Status | Concluded |
Related Work | |
Updates |
N/A
|
People |
Aria Ilyad Ahmad, Research Fellow, Global Health Foresighting Alum
|
You may also be interested in...
Join Us This September for Our Global Health Research Seminar Series
We are kicking off the 2022-23 academic year at the Dahdaleh Institute with some wonderful global health research talks this September: disaster management, humanitarian response, occupational health, and planetary health. All events will be delivered in ...Read more about this Post
Recap – The Protection Gaps that Venezuelan LGBTQI+ Asylum Seekers Face in Brazil
On October 19, the Dahdaleh Institute for Global Health Research and the Centre for Research in Latin America and the Caribbean co-sponsored a seminar with Yvonne Su (faculty fellow) and Gerson Scheidweiler (postdoctoral fellow). Yvonne and ...Read more about this Post
Dahdaleh Institute Researchers Awarded Major Funding from SSHRC
Congratulations to Dahdaleh Institute faculty fellow and PI Amrita Daftary and director and co-applicant James Orbinski, who received a 3-year Social Sciences & Humanities Research Council of Canada (SSHRC) Partnership Development Grant for "A Global ...Read more about this Post